133 results on '"Mannalithara, Ajitha"'
Search Results
2. Exploring human–artificial intelligence interactions in a negative pragmatic trial of computer-aided polyp detection
3. Hepatitis C Screening in Post–Baby Boomer Generation Americans: One Size Does Not Fit All
4. Computer-aided Detection of Polyps Does Not Improve Colonoscopist Performance in a Pragmatic Implementation Trial
5. Cost-Effectiveness of Earlier or More Intensive Colorectal Cancer Screening in Overweight and Obese Patients
6. Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45–49 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines
7. National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States
8. Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients With Chronic Hepatitis B
9. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
10. Adenoma and Serrated Lesion Detection by Colonoscopy Indication: The ADR-ESS (ADR Extended to all Screening/Surveillance) Score
11. Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis
12. Migration of Patients for Liver Transplantation and Waitlist Outcomes
13. Colorectal cancer screening at age 45 years in Israel: Cost‐effectiveness and global implications.
14. Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study
15. A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study
16. MELD 3.0 for adolescent liver transplant candidates.
17. Obesity, Abdominal Obesity, Physical Activity, and Caloric Intake in US Adults: 1988 to 2010
18. Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States
19. Improved posttransplant mortality after share 35 for liver transplantation
20. Proximal and Distal Colorectal Cancer Resection Rates in the United States Since Widespread Screening by Colonoscopy
21. Mortality in patients with end‐stage liver disease above model for end‐stage liver disease 3.0 of 40.
22. Diagnosis, Comorbidities, and Management of Irritable Bowel Syndrome in Patients in a Large Health Maintenance Organization
23. The steatosis‐associated fibrosis estimator (SAFE) score: A tool to detect low‐risk NAFLD in primary care.
24. Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals
25. Risk of perforation from a colonoscopy in adults: a large population-based study
26. Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity
27. Utilization and Antiviral Therapy in Patients with Chronic Hepatitis C: Analysis of Ambulatory Care Visits in the US
28. Incidence and Risk of Intestinal and Extra-intestinal Complications in Medicaid Patients with Inflammatory Bowel Disease: A 5-Year Population-Based Study
29. Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: a large prospective observational cohort study
30. Tu1636 SAFE SCORE PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS IN LIVER TRANSPLANTATION RECIPIENTS.
31. Su1547 PREVALENCE OF STEATOTIC LIVER DISEASE IN THE US USING THE NEW NOMENCLATURE.
32. Su1148 FEASIBILITY OF DETERMINING DIFFERENCES IN EARLY-STAGE VS. LATE-STAGE COLORECTAL (CRC) CANCER SENSITIVITY OF EMERGING BLOOD-BASED BIOMARKERS FOR CRC SCREENING.
33. Sa1146 COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF COLORECTAL CANCER (CRC) SCREENING WITH BLOOD-BASED BIOMARKERS (LIQUID BIOPSY) VS. FECAL TESTS OR COLONOSCOPY.
34. 473 RANDOMIZED CONTROLLED TRIAL OF FECAL IMMUNOCHEMICAL TEST (FIT)-BASED MAILED OUTREACH OFFERING ACTIVE CHOICE (FIT OR COLONOSCOPY UP-FRONT) VS. SEQUENTIAL CHOICE (INITIAL FIT, LATER INVITATION FOR COLONOSCOPY) FOR COLORECTAL CANCER (CRC) SCREENING.
35. Age-Specific Rates and Time-Courses of Gastrointestinal and Nongastrointestinal Complications Associated With Screening/Surveillance Colonoscopy.
36. Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis.
37. Developing and Deploying an Automated Quality Reporting System in Your Practice: Learning From the Stanford Colonoscopy Quality Assurance Program.
38. Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non–Hepatocellular Carcinoma Factors.
39. Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.
40. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
41. BELIEFS AND ATTITUDES ABOUT ARTIFICIAL INTELLIGENCE (AI) AMONG COLONOSCOPIST PARTICIPANTS IN A PRAGMATIC IMPLEMENTATION TRIAL OF COMPUTER-AIDED DETECTION (CADE) OF POLYPS THAT DID NOT REPLICATE THE POSITIVE RESULTS OF RANDOMIZED TRIALS.
42. Reply.
43. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.
44. Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis.
45. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States.
46. Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States.
47. 386 NOVEL MACHINE LEARNING APPROACHES TO THE NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN NAFLD.
48. 745 COMPUTER-AIDED DETECTION OF POLYPS DOES NOT IMPROVE COLONOSCOPIST PERFORMANCE IN A PRAGMATIC IMPLEMENTATION TRIAL.
49. Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool.
50. Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.